Inscription Capital’s HCA Healthcare HCA Stock Holding History

Inscription Capital’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99M	Sell	5,100 -238	-4%	-$101K	0.18%	104
2026 Q1	$2.53M	Sell	5,338 -172	-3%	-$86.6K	0.27%	66
2025 Q4	$2.57M	Sell	5,510 -329	-6%	-$153K	0.26%	56
2025 Q3	$2.49M	Buy	5,839 +1,845	+46%	+$715K	0.27%	56
2025 Q2	$1.53M	Buy	3,994 +549	+16%	+$198K	0.22%	74
2025 Q1	$1.15M	Buy	+3,445	New	+$1.11M	0.19%	88
2024 Q3	$1.38M	Buy	3,386 +18	+0.5%	+$6.59K	0.2%	83
2024 Q2	$1.08M	Sell	3,368 -77	-2%	-$25K	0.17%	94
2024 Q1	$1.15M	Hold	3,445	–	–	0.19%	88
2023 Q4	$932K	Buy	3,445 +394	+13%	+$97.4K	0.25%	70
2023 Q3	$750K	Sell	3,051 -90	-3%	-$24.6K	0.24%	73
2023 Q2	$953K	Buy	3,141 +90	+3%	+$25K	0.3%	63
2023 Q1	$804K	Hold	3,051	–	–	0.21%	85
2022 Q4	$732K	Hold	3,051	–	–	0.25%	85
2022 Q3	$561K	Hold	3,051	–	–	0.16%	101
2022 Q2	$513K	Hold	3,051	–	–	0.09%	150
2022 Q1	$765K	Hold	3,051	–	–	0.22%	94
2021 Q4	$784K	Hold	3,051	–	–	0.21%	98
2021 Q3	$741K	Buy	+3,051	New	+$746K	0.23%	89
2021 Q2	–	Sell	-3,655	Closed	-$688K	–	349
2021 Q1	$688K	Hold	3,655	–	–	0.23%	90
2020 Q4	$601K	Hold	3,655	–	–	0.23%	92
2020 Q3	$456K	Sell	3,655 -225	-6%	-$27.8K	0.2%	95
2020 Q2	$377K	Hold	3,880	–	–	0.21%	85
2020 Q1	$349K	Hold	3,880	–	–	0.23%	82
2019 Q4	$574K	Buy	+3,880	New	+$521K	0.25%	80

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Inscription Capital's HCA Position: Q2 2026 in Review

Inscription Capital reduced its HCA Healthcare (HCA) stake by 4.5% in Q2 2026, selling an estimated $101K and leaving 5,100 shares worth $1.99M. The position accounts for 0.18% of the portfolio, ranked #104.

Inscription Capital first reported a position in HCA in Q4 2019 and has held it in 25 quarters since. The position peaked at $2.57M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Inscription Capital held 5,100 shares of HCA Healthcare worth $1.99M as of Q2 2026.
Inscription Capital sold 238 HCA Healthcare shares in Q2 2026, an estimated $101K.
HCA Healthcare made up 0.18% of Inscription Capital's portfolio in Q2 2026, its #104 holding.
Inscription Capital first reported a position in HCA Healthcare in Q4 2019 and has held it in 25 quarters since.
Inscription Capital's HCA Healthcare position peaked at $2.57M in Q4 2025.
1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.